SK284505B6 - Použitie kombinácie diolu a alfa-hydroxykyseliny vo vehikule na prípravu liečiva určeného na topickú liečbu hyperkeratóznych kožných ochorení - Google Patents

Použitie kombinácie diolu a alfa-hydroxykyseliny vo vehikule na prípravu liečiva určeného na topickú liečbu hyperkeratóznych kožných ochorení Download PDF

Info

Publication number
SK284505B6
SK284505B6 SK743-2000A SK7432000A SK284505B6 SK 284505 B6 SK284505 B6 SK 284505B6 SK 7432000 A SK7432000 A SK 7432000A SK 284505 B6 SK284505 B6 SK 284505B6
Authority
SK
Slovakia
Prior art keywords
alpha
vehicle
diol
skin diseases
hydroxy acid
Prior art date
Application number
SK743-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK7432000A3 (en
Inventor
Agneta Ganemo
Original Assignee
Yamanouchi Europe B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Europe B.V. filed Critical Yamanouchi Europe B.V.
Publication of SK7432000A3 publication Critical patent/SK7432000A3/sk
Publication of SK284505B6 publication Critical patent/SK284505B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK743-2000A 1997-11-25 1998-11-25 Použitie kombinácie diolu a alfa-hydroxykyseliny vo vehikule na prípravu liečiva určeného na topickú liečbu hyperkeratóznych kožných ochorení SK284505B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203681 1997-11-25
PCT/EP1998/007759 WO1999026617A1 (en) 1997-11-25 1998-11-25 Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases

Publications (2)

Publication Number Publication Date
SK7432000A3 SK7432000A3 (en) 2001-05-10
SK284505B6 true SK284505B6 (sk) 2005-05-05

Family

ID=8228970

Family Applications (1)

Application Number Title Priority Date Filing Date
SK743-2000A SK284505B6 (sk) 1997-11-25 1998-11-25 Použitie kombinácie diolu a alfa-hydroxykyseliny vo vehikule na prípravu liečiva určeného na topickú liečbu hyperkeratóznych kožných ochorení

Country Status (22)

Country Link
US (1) US6399082B1 (de)
EP (1) EP1032378B1 (de)
CN (1) CN1140266C (de)
AT (1) ATE213939T1 (de)
AU (1) AU754420B2 (de)
BG (1) BG64743B1 (de)
BR (1) BR9815016A (de)
CA (1) CA2310049C (de)
CZ (1) CZ290165B6 (de)
DE (1) DE69804130T2 (de)
DK (1) DK1032378T3 (de)
ES (1) ES2174533T3 (de)
HK (1) HK1034194A1 (de)
HU (1) HU226065B1 (de)
IS (1) IS2147B (de)
NO (1) NO320100B1 (de)
NZ (1) NZ504458A (de)
PL (1) PL190023B1 (de)
PT (1) PT1032378E (de)
SK (1) SK284505B6 (de)
TR (1) TR200001486T2 (de)
WO (1) WO1999026617A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5778367A (en) * 1995-12-14 1998-07-07 Network Engineering Software, Inc. Automated on-line information service and directory, particularly for the world wide web
WO1999060167A1 (en) * 1998-05-21 1999-11-25 Isis Pharmaceuticals, Inc. Compositions and methods for topical delivery of oligonucleotides
US6410036B1 (en) * 2000-05-04 2002-06-25 E-L Management Corp. Eutectic mixtures in cosmetic compositions
AU2002314847A1 (en) 2001-05-31 2002-12-09 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
USRE46558E1 (en) 2005-04-28 2017-09-26 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
US20060257337A1 (en) * 2005-04-28 2006-11-16 David Sherris Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
US8475776B2 (en) 2005-04-28 2013-07-02 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
US20070189989A1 (en) * 2006-02-16 2007-08-16 Cantwell Maggie Y Cosmetic compositions and methods of making and using the compositions
CA2719853A1 (en) * 2008-03-25 2009-10-01 Paloma Pharmaceuticals, Inc. Methods of treating fibrotic disorders
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
ES2404156T3 (es) * 2009-04-13 2013-05-24 Vanangamudi Subramaniam SULUR Una crema medicinal con ácido fusídico hecha utilizando fusidato de sodio e incorporando un biopolímero y el proceso para hacerla
AU2010244983B2 (en) * 2009-05-08 2015-07-16 Allmedic Pty Ltd Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition
KR101962658B1 (ko) * 2010-11-04 2019-07-31 442 벤쳐스 엘엘씨 피부 상태를 치료하기 위한 조성물 및 방법
WO2012112791A1 (en) 2011-02-16 2012-08-23 Paloma Pharmaceuticals, Inc. Radiation countermeasure agents
GB2540764A (en) * 2015-07-24 2017-02-01 Fontus Health Ltd Topical composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021572A (en) * 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
US5525635A (en) * 1986-02-04 1996-06-11 Moberg; Sven Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
SE462139B (sv) * 1986-02-04 1990-05-14 Sven Moberg Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem
AU658608B2 (en) * 1991-03-25 1995-04-27 Astellas Pharma Europe B.V. Topical preparation containing a suspension of solid lipid particles
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
US5407958A (en) * 1993-07-30 1995-04-18 Beauticontrol Cosmetics, Inc. Therapeutic skin composition
AU7656894A (en) * 1993-09-15 1995-04-03 Unilever Plc Skin care method and composition

Also Published As

Publication number Publication date
NO320100B1 (no) 2005-10-24
EP1032378A1 (de) 2000-09-06
PL190023B1 (pl) 2005-10-31
HUP0100066A2 (hu) 2001-08-28
DE69804130D1 (de) 2002-04-11
DE69804130T2 (de) 2002-07-25
PL340679A1 (en) 2001-02-12
SK7432000A3 (en) 2001-05-10
CA2310049C (en) 2008-02-19
NO20002649D0 (no) 2000-05-24
WO1999026617A1 (en) 1999-06-03
ES2174533T3 (es) 2002-11-01
HU226065B1 (hu) 2008-04-28
BG104470A (en) 2001-03-30
DK1032378T3 (da) 2002-04-15
ATE213939T1 (de) 2002-03-15
CA2310049A1 (en) 1999-06-03
NZ504458A (en) 2002-03-01
HK1034194A1 (en) 2001-10-19
EP1032378B1 (de) 2002-03-06
CN1280495A (zh) 2001-01-17
BR9815016A (pt) 2000-10-03
CZ20001920A3 (cs) 2001-04-11
TR200001486T2 (tr) 2001-07-23
PT1032378E (pt) 2002-07-31
IS5505A (is) 2000-05-23
IS2147B (is) 2006-09-15
CN1140266C (zh) 2004-03-03
CZ290165B6 (cs) 2002-06-12
HUP0100066A3 (en) 2006-07-28
US6399082B1 (en) 2002-06-04
AU754420B2 (en) 2002-11-14
NO20002649L (no) 2000-07-24
BG64743B1 (bg) 2006-02-28
AU1965999A (en) 1999-06-15

Similar Documents

Publication Publication Date Title
US4839159A (en) Topical L-carnitine composition
JP2686365B2 (ja) 陸生哺乳類の皮膚炎治療剤
US4760096A (en) Moisturizing skin preparation
CA1336762C (en) Method and composition for treating and preventing dry skin disorders
US5616332A (en) Cosmetic skin-renewal-stimulating composition with long-term irritation control
US4871752A (en) Use of aryloxycarboxylic acid derivatives against dermatological diseases
JP2001510487A (ja) 遊離スフィンゴイド塩基及びセラミドの組合せを含む組成物並びにその使用
SK284505B6 (sk) Použitie kombinácie diolu a alfa-hydroxykyseliny vo vehikule na prípravu liečiva určeného na topickú liečbu hyperkeratóznych kožných ochorení
US20060127342A1 (en) Taurine-based compositions, therapeutic methods, and assays
JPS63192703A (ja) 皮膚外用剤
US5045559A (en) Treatment of skin disorders
US20160243011A1 (en) Formulations Comprising Idebenone, N-Acetyl-S-Farnesyl-L-Cysteine and Ergothioneine and Uses Thereof
EP0100827B1 (de) Pharmazeutische Zusammensetzung eine alifatische Aminosulfonsäure enthaltend
US5508034A (en) Method and composition for treating and preventing dry skin disorders
TW202100138A (zh) 外用組成物
WO1999026613A1 (en) Aminoguanidine compositions for treating skin proliferative diseases
EP0020532B1 (de) Haut-zusammensetzung auf der basis von lezithin-triäthanolamin
US20210052527A1 (en) N-bromotaurine solutions and emulsions against abnormal cells
EP1080719A2 (de) Verfahren zur Potenzierung der Wirksamkeit topischer Wirkstoffe durch Mono-acyl-(lyso)-glyceropholipide
MXPA00005078A (en) Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases
JP2017031133A (ja) フコキサンチンによるかゆみ抑制
CZ20021279A3 (cs) Farmaceutické a/nebo kosmetické přípravky
CA2270561A1 (en) Synergistic gold-containing compositions
JPH0529007B2 (de)
IE54490B1 (en) Pharmaceutical composition containing an aliphatic amino sulphonic acid

Legal Events

Date Code Title Description
TE4A Change of owner's address

Owner name: ASTELLAS PHARMA EUROPE B.V., BE LEIDEN, NL

Effective date: 20160511

PC4A Assignment and transfer of rights

Owner name: LEO PHARMA A/S, BALLERUP, DK

Free format text: FORMER OWNER: ASTELLAS PHARMA EUROPE B.V., BE LEIDEN, NL

Effective date: 20160523

MK4A Expiry of patent

Expiry date: 20181125